Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Multiple Sclerosis

  Free Subscription


1 Acta Neurol Scand
1 AJNR Am J Neuroradiol
2 Ann Neurol
1 Arch Phys Med Rehabil
2 J Neuroimmunol
1 J Neurol
5 Mult Scler
1 Nervenarzt
2 Neurology
1 Proc Natl Acad Sci U S A

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Acta Neurol Scand

  1. OLSSON A, Gustavsen S, Gisselo Lauridsen K, Chenoufi Hasselbalch I, et al
    Neutrophil-to-lymphocyte ratio and CRP as biomarkers in multiple sclerosis: A systematic review.
    Acta Neurol Scand. 2021 Feb 16. doi: 10.1111/ane.13401.
    PubMed         Abstract available

    AJNR Am J Neuroradiol

  2. JANG H, Ma YJ, Chang EY, Fazeli S, et al
    Inversion Recovery Ultrashort TE MR Imaging of Myelin is Significantly Correlated with Disability in Patients with Multiple Sclerosis.
    AJNR Am J Neuroradiol. 2021 Feb 18. pii: ajnr.A7006. doi: 10.3174/ajnr.A7006.
    PubMed         Abstract available

    Ann Neurol

  3. DE MEO E, Bonacchi R, Moiola L, Colombo B, et al
    Early predictors of 9-year disability in pediatric multiple sclerosis.
    Ann Neurol. 2021 Feb 17. doi: 10.1002/ana.26052.
    PubMed         Abstract available

  4. FADDA G, Banwell B, Waters P, Marrie RA, et al
    Silent new brain MRI lesions in children with MOG-antibody associated disease.
    Ann Neurol. 2020 Nov 19. doi: 10.1002/ana.25957.
    PubMed         Abstract available

    Arch Phys Med Rehabil

  5. GREENBERG T, Soll R, Dolev M, Kalron A, et al
    Reproducibility and Convergent Validity of the Sitting-Rising Test in People with Multiple Sclerosis.
    Arch Phys Med Rehabil. 2021 Feb 10. pii: S0003-9993(21)00149.
    PubMed         Abstract available

    J Neuroimmunol

  6. LI Q, Liu Y, Zeng Y
    Questions about data: Importance of serum amyloid A level in patients with multiple sclerosis.
    J Neuroimmunol. 2021;353:577516.

  7. UCHIDA N, Mori K, Fujita-Nakata M, Nakanishi M, et al
    Systemic cellular immunity and neuroinflammation during acute flare-up in multiple sclerosis and neuromyelitis optica spectrum disorder patients.
    J Neuroimmunol. 2021;353:577500.
    PubMed         Abstract available

    J Neurol

  8. JAKIMOVSKI D, Benedict RHB, Weinstock-Guttman B, Ozel O, et al
    Visual deficits and cognitive assessment of multiple sclerosis: confounder, correlate, or both?
    J Neurol. 2021 Feb 15. pii: 10.1007/s00415-021-10437.
    PubMed         Abstract available

    Mult Scler

  9. BESSING B, Hussain MA, Claflin SB, Chen J, et al
    Changes in multiple sclerosis symptoms are associated with changes in work productivity of people living with multiple sclerosis.
    Mult Scler. 2021 Feb 16:1352458521994557. doi: 10.1177/1352458521994557.
    PubMed         Abstract available

  10. HARROUD A, Marrie RA, Fitzgerald KC, Salter A, et al
    Mendelian randomization provides no evidence for a causal role in the bidirectional relationship between depression and multiple sclerosis.
    Mult Scler. 2021 Feb 16:1352458521993075. doi: 10.1177/1352458521993075.
    PubMed         Abstract available

  11. LEMA DOPICO A, Choi S, Hua J, Li X, et al
    Multi-layer analysis of quantitative 7 T magnetic resonance imaging in the cortex of multiple sclerosis patients reveals pathology associated with disability.
    Mult Scler. 2021 Feb 18:1352458521994556. doi: 10.1177/1352458521994556.
    PubMed         Abstract available

  12. BINZER S, Jiang X, Hillert J, Manouchehrinia A, et al
    Depression and multiple sclerosis: A bidirectional Mendelian randomisation study.
    Mult Scler. 2021 Feb 19:1352458521996601. doi: 10.1177/1352458521996601.
    PubMed         Abstract available

  13. HARROUD A, Manousaki D, Butler-Laporte G, Mitchell RE, et al
    The relative contributions of obesity, vitamin D, leptin, and adiponectin to multiple sclerosis risk: A Mendelian randomization mediation analysis.
    Mult Scler. 2021 Feb 19:1352458521995484. doi: 10.1177/1352458521995484.
    PubMed         Abstract available


  14. PENNER IK, Filser M, Batge SJ, Renner A, et al
    [Clinical practicability of the cognitive screening battery BICAMS in patients with multiple sclerosis: results of the feasibility study in Germany].
    Nervenarzt. 2021 Feb 17. pii: 10.1007/s00115-021-01073.
    PubMed         Abstract available


  15. KALAITZIDIS G, Calabresi PA
    Is Cerebrospinal Fluid Responsible for Innate Immune Cell Activation and Neurotoxicity in Multiple Sclerosis?
    Neurology. 2021 Feb 15. pii: WNL.0000000000011694.

  16. Evaluation of Multiple Sclerosis Disability Outcome Measures Using Pooled Clinical Trial Data.
    Neurology. 2021 Feb 12. pii: WNL.0000000000011677.

    Proc Natl Acad Sci U S A

  17. KHAW YM, Tierney A, Cunningham C, Soto-Diaz K, et al
    Astrocytes lure CXCR2-expressing CD4(+) T cells to gray matter via TAK1-mediated chemokine production in a mouse model of multiple sclerosis.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.